Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Levice – page 10

155 clinical trials in Levice, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Levice at a glance
155
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

155 trials in Levice

Open in trial search

Breast cancer

Not recruiting

Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

Hypertriglyceridaemia

Not recruiting

Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Major depression

Not recruiting

Study on the Effects of BH-200 (Nelivaptan) for Patients with Major Depressive Disorder

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Nelivaptan
  • Sponsor:HMNC Holding GmbH

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Gilead Sciences Inc.

Hidradenitis

Not recruiting

Study of lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Janssen Cilag International

Cardiac failure

Not recruiting

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Novartis Pharma AG

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

Registered drug
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Alopecia areata

Not recruiting

Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Cachexia

Not recruiting

Study of ponsegromab for patients with cancer cachexia and elevated GDF-15 levels

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Ponsegromab
  • Sponsor:Pfizer Inc.

Hepatic cirrhosis

Not recruiting

Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:AstraZeneca AB

Study on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Levice

What the registry says about research in the country

01 Cardiovascular Diseases

In Levice, cardiovascular disease research focuses on preventing serious events such as stroke, heart attack, and other vascular complications. These studies are designed to assess new options for stroke prevention, atherosclerotic cardiovascular disease, and related risk reduction.

  • Acute ischemic stroke and high-risk transient ischemic attack
  • Atrial fibrillation with prevention of stroke or systemic embolism
  • Atherosclerotic cardiovascular disease and systemic inflammation
  • High LDL cholesterol and broader cardiovascular risk

The trials are mainly evaluating whether new treatments can improve protection against major cardiovascular events and support better long-term outcomes.

02 Respiratory Tract Diseases

A large share of the clinical research in Levice is centered on asthma and chronic obstructive pulmonary disease. These studies explore ways to improve breathing control, reduce flare-ups, and slow the decline in lung function in people with persistent respiratory symptoms.

  • Moderate to severe asthma and uncontrolled asthma
  • Chronic obstructive pulmonary disease and chronic bronchitis
  • Asthma with frequent exacerbations
  • Severe COPD outcomes and lung function decline

Overall, the research is aimed at testing new therapies and combination treatments that may help people breathe more easily and stay stable for longer.

03 Nutritional and Metabolic Diseases

Clinical trials in this area examine overweight, obesity, type 2 diabetes, and hyperlipidemia. The goal is to better understand treatment approaches that may support weight reduction and improve metabolic health.

  • Overweight or obesity with type 2 diabetes
  • Hyperlipidemia and elevated cardiovascular risk
  • Weight management in people with metabolic disease
  • Metabolic risk linked to heart and vascular complications

These studies are mainly testing whether newer therapies can improve key health markers and reduce the burden of metabolic disease.

04 Skin and Connective Tissue Diseases

Research in skin and connective tissue diseases is represented by studies on chronic spontaneous urticaria. The main purpose is to evaluate treatments that may improve symptom control and provide longer-lasting relief for people with persistent allergic skin disease.

  • Chronic spontaneous urticaria
  • Long-term symptom control
  • Relapse prevention and treatment durability

This area adds a focused immunology component to the clinical trial landscape in Levice.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.